Colorectal cancer screening examination and early detection method
WO2020084072A1
Vaccination and antibody generation platform
EP3812765A1
Method and system for closed-loop live-cell imaging
WO2020053300A1
Improved anti-flt3 antigen binding proteins
EP3785731A1
Treating non-alcoholic steatohepatitis (nash) and hepatocellular carcinoma (hcc) with compounds binding the ectodomain of platelet glycoprotein ib (gpib) alpha
US2020030356A1
Pancreatic cancer therapy and diagnosis
WO2020025684A1
Method and system for augmented imaging in open treatment using multispectral information
WO2020025710A1
Micro rna for use in the prevention and/or treatment of invasive cancer
WO2020025696A1
Method and system for augmented imaging using multispectral information
EP3754015A1
Optimized parvovirus h-1 production
EP3721894A1
Interleukin-4-induced gene 1 (il4i1) as a biomarker and uses thereof
EP3715471A1
Ahr signature marker set
EP3699595A1
Use of bmmf1 rep protein as a biomarker for breast cancer
EP3699594A1
Use of bmmf1 rep protein as a biomarker for prostate cancer
EP3692984A1
Annexin-coated particles
EP3693740A1
Improved dithiocarmabate based compounds, therapies and diagnostics
EP3686289A1
Cmi sequences as an early marker for the future development of cancer, atherosclerosis, diabetes and diseases of the cns and as a target for the treatment and prevention of these diseases
EP3657172A1
Method for predicting the clinical response of oncolytic parvovirus h1 (h-1pv) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient´s sample
EP3653702A1
Crystal structure of a replication protein encoded by a plasmid isolated from a multiple sclerosis patient
